Buckley Capital Advisors' Q1 2025 letter highlighted their performance amid economic uncertainty due to Trump's tariff plans. They focus on fundamentally strong companies, like Verona Pharma plc (NASDAQ:VRNA), with potential for high returns.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing